3D Medicines (HKSE:01244) Dividends per Share: HK$0.00 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01244 3D Medicines Inc HKSE:01244
47 GF Score
Price HK$2.36
GF Value HK$3.09
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is 3D Medicines Dividends per Share?

3D Medicines HKSE:01244 +4.19% 47 Dividends per Share is HK$0.00 as of Dec. 2025. GuruFocus rates HKSE:01244 with a GF Score™ of 47/100 and a GF Value™ of HK$3.09 (Modestly Undervalued). The stock has 5 warning signs investors should review.

3D Medicines's dividends per share for the six months ended in Dec. 2025 was HK$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2025 was 0.00. As of today, 3D Medicines's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

3D Medicines  (HKSE:01244) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

3D Medicines's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=/ -0.37223209189272
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Medicines Dividends per Share Related Terms

3D Medicines Dividends per Share Historical Data

* Premium members only.

The historical data trend for 3D Medicines's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Medicines Dividends per Share Chart

3D Medicines Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividends per Share
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

3D Medicines Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividends per Share Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

HKSE:01244 vs VRTX, REGN, MRNA: Dividends per Share Comparison

For the Biotechnology subindustry, 3D Medicines's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Medicines Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Medicines's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where 3D Medicines's Dividend Yield % falls into.


HKSE:01244
47GF Score
3D Medicines Inc HKSE:01244
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3D Medicines Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of HK$0.00 mean?
3D Medicines (HKSE:01244) has a Dividends per Share of HK$0.00 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on 3D Medicines and its competitors.
Is 3D Medicines' Dividends per Share too high?
3D Medicines' current Dividends per Share is HK$0.00. Overall, 3D Medicines has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 3D Medicines' Dividends per Share compare to VRTX and REGN?
3D Medicines' Dividends per Share of HK$0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on 3D Medicines and its competitors. 3D Medicines's current Dividends per Share is HK$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3D Medicines stock overvalued right now?
Based on GuruFocus' analysis, 3D Medicines (HKSE:01244) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$3.09, compared to a current price of HK$2.36 — trading 23.6% below its estimated fair value. The current Dividends per Share is HK$0.00. 3D Medicines' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For 3D Medicines (HKSE:01244), the current Dividends per Share is HK$0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3D Medicines (HKSE:01244) Overvalued in 2026?

Based on GuruFocus' analysis, 3D Medicines stock appears to be undervalued. The current stock price of HK$2.36 is trading 23.6% below its estimated GF Value™ of HK$3.09. GuruFocus considers 3D Medicines to be Modestly Undervalued.

Key valuation signals for HKSE:01244:

  • Dividends per Share: HK$0.00
  • GF Value™: HK$3.09 vs. price of HK$2.36 (23.6% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the HKSE:01244 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3D Medicines Business Description

Address No. 3 and No. 5, Laiyang Road, Shandong Province, Shinan District, Qingdao, CHN
3D Medicines Inc is an investment holding company. The company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products.It develops differentiated immuno-oncology drugs, helping cancer patients live with prolonged survival time and quality of life. It generates all of its revenue from China. Its commercialized product is Envita.
47GF Score

Get the complete analysis for HKSE:01244

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.36
Price
HK$3.09
GF Value